Length of Trial Period and Fit of Standard Survival Extrapolation Distributions for Ipilimumab in Melanoma
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.067
https://www.valueinhealthjournal.com/article/S1098-3015(17)30401-1/fulltext
Title :
Length of Trial Period and Fit of Standard Survival Extrapolation Distributions for Ipilimumab in Melanoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30401-1&doi=10.1016/j.jval.2017.08.067
First page :
A409
Section Title :
BREAKOUT SESSION XIII
Open access? :
No
Section Order :
51